INTRODUCTION
In rec ent years, o ral cont ro lled d rug deliv ery has att racted g reat att ent io n in pharmaceut ica l field in o rder t o att ain imp ro ved therapeut ic ad van tag es, such as short eli minat ion half life, systemic to xicit ies an d pat ient co mp lian ce so fo rth. 1 Nanop art icles med iat ed d rug deliv ery red uces the frequ en cy o f dos ing in therapeut ic cond it ions by sustained d rug release and maintains its effect ive d rug co ncent rat ion in the syste mic circu lat ion over a long er period o f time. 2 Even th ough , the systemic d ru g d eliv ery o f nanosyst ems is in market , o ral d rug d eliv ery is imp o rtant in v ario us clin ical co nd it ions, part icu larly gast ro in test in al t ract d iso rd ers. Mo re rece nt ly , th e pu rsu it an d exp lo rat ion o f dev ices des ign ed t o b e ret ain ed d rugs in the upp er p art o f the gast ro int est inal t rac t ( GIT) h as adv an ced cons istent ly in t er ms o f t ech no lo gy and d ivers it y, enco mpass in g a v ariet y o f b iosyst ems an d dev ices like float ing systems , s welling -exp and in g systems, bioad hes iv e system, mo d ified -shape syste m et c. 3 Gast ric ret ent ion has ad van tag es in deliv erin g of dru g wit h narro w abso rpt io n in t he u pper part o f GIT. A lso , long er residen ce t ime in the sto mach cou ld b e adv ant ag eous fo r local act ion in th e GIT, part icu larly treat ment o f pept ic u lcer d is eases .
Gast ro retent ive d ru g deliv ery is one o f the sit e spec ific d eliv eries fo r che moth erap eut ic d ru gs eith er at sto mach o r at int est ine lev el. 4 It is obtained by ret ain in g d osag e fo rm into sto mach and d ru g is b eing released at con tro lled man ner to spec ific s ite either in sto mac h , du odenu m and in test in e. Naring en in (NR G, 4', 5, 7-t rihy d ro xy flavanon e), a nat u rally occu rrin g flav ono id, and ag ly con e o f naring in , is wid ely p resen t in cit rus fru its , t o mat oes , cherries, grap efru it and coco a. 5,6,7 ,8,9 It is well kno wn fo r v arious b io log ical act ions, such as ant io xid ant , an t i-in flammato ry, ant i-u lcer, as well as an t i-carcin ogen ic effects . 10, 11 Th e d rug , Yet it su ffers fro m b iop harmaceut ical rest rict io ns due to its poo r water so lub ility wh ich resu lts in poo r abso rpt ion and sho rt h alf life about 2 ho urs . 12, 13 A lso NRG h as b een rep o rted to h ave short d rug res id en ce t ime in the sto mach .
14 So it is necessary to d ev elop g ast ro reten t ive delivery system t o maintain its integrity .
In the p resent stu dy was an at temp t to des ign and fo rmu lat e NRG-loaded g ast ro retent ive mu co adh es ive po ly meric n ano part icles us ing synthet ic po ly mers such as Eud rag it E 100 ( EE 100) an d po ly v iny l alcoho l (P VA ). The
ABS TRAC T
Nanop art icles mediated oral drug delivery system has attract ed great attention in pharmacology t o attain improved therapeutic index of chemotherap eut ic drugs . In t he pres ent st udy, naringenin (N RG ) -loaded gast roretentive mucoadhes ive poly meric nanoparticles has been designed and invest igat ed its application in oral drug delivery system. Naringenin loaded gastroretent ive mucoadhes ive poly meric nanoparticles (NM PN) w ere prep ared by thermal decompos it ion mediat ed nanoprecip itat ion method. F ormulated NM PN w er e charact eriz ed and investigat ed for its mucoadhes ive prop ert ies by sw elling and in v itro mucoadhes ion studies . The results indicat ed that the formulated NM PN w ere in the siz e of 66±7nm by dynamic light s cattering analys is and the maximum drug loading efficiency w as obs erved around 94.6±0.28%. F urt her the drug releas e st udies s how ed that NM P N exhibited sust ained drug releas e in st imulat ed gastric fluid (SGF ; pH= 1.2). P harmacokinetic studies revealed t hat the formulated NM PN are highly biocompat ible and s how ed enhanced therapeut ic efficacy comp ared t o free naringenin. The overall findings demonstrat ed that the gastroret ent ive mucoadhes ive poly meric nanoparticles can act as a promis ing candidate w ith gastroprotect ive applications in biomedical res earch.
Keywords: Naringenin, drug delivery, stimulated gastric fluid, mucoadhesive phys ico ch emical ch aracterizat ion o f NM PN was ca rried by d yna mic light scattering (DLS), zeta poten t ial, lo ad in g efficiency, d ru g load ing co nten t, fou rier t rans fo rm in frared spect roscopy (FTIR), nuclear mag net ic reson ance spectroscop y ( 1 H NM R) and field emiss ion t rans miss io n elect ron mic rosco py (FE-TEM ) stud ies. Th e mu co adh es ive pro pert ies were det ermin ed by s wellin g and in vit ro mucoadhes io n stud ies. A lso , d ru g release in stimu lat ed gast ric and in test in al flu ids h as been assessed. The in vivo p harmaco kinet ic p attern of NM PN was also stud ied in W istar rats.
MATER IALS AND METHODS

Eudragit
® E 100 (EE 100) was obtained from Evonik Industries, Mumbai, India. Naringenin (NRG) was purchased from Sig ma -Aldrich Chemicals, St. Louis, MO., Mu mbai, India. While other fine chemicals, reagents and solvents used for the experiments were of analytical grade, purchased from Merck Ltd., Mumbai, India. Milli Q water was used in all experiments.
Formul ation of NMPN: 15, 16, 17 NMPN were formu lated using a nanoprecipitation technique with slight modifications. The internal organic phase composed of 50 mg NRG and 500 mg EE 100 in 25ml of ethanol. This internal solution was quickly injected into the 75ml external aqueous solution containing 500 mg of PVA , and then the solutions were stirred. Then the emulsion was ripened at 100 °C for an hour by introducing the thermal deco mposition and cooled in an appropriate manner. The reaction mixture was purified by centrifugation at 6000 rp m to remove small particles. The precipitate was main ly co mposed of nanoparticles. It was lyophilized and stored for further use.
Physicochemical characterization Techniques: DLS analysis of NMPN:
Measurement of particle size, polydispersity index of the free NRG and NMPN was performed by Photon Correlation Spectroscopy known as Dynamic Light Scattering (Nano-ZS90 -Malvern Instruments). Each samp le was appropriately diluted 10 fold with ultra purified water and measured at 25° C and 90° scattering angle, recorded for 180 s. Each value was measured in triplicate. The results were showed as mean ± SD d istribution. Surface charge of the NMPN were also characterized with Zeta potential (ζ) using a Malvern Nano-ZS90. The measurements were done using an aqueous dip cell in an automatic mode by placing diluted samples (with ult ra-purified water) in the capillary measurement cell and cell position was adjusted.
H Nuclear Magnetic Resonance ( H NMR):
18
The 1 H NMR spectra of free NRG and NM PN were recorded using a JEOL Alpha 400 spectrometer. An amount of 50 mg of each sample was dissolved in 1.0 ml of DMSO-d6 and each sample was measured and recorded in triplicate.
Fourier Transform Infrared S pectroscopy (FTIR):
Infrared spectra were obtained using a Perkin Elmer FTIR spectrometer. In order to collect the spectra, a small amount of the compound was used by compression in KBr tablets. The IR spectra were obtained in the spectral region 400-4000cm-1 using resolution 4cm -1 and 10 co-added scans. The spectrum of the KBr pellet was used as background. The spectra presented were baseline corrected and normalized.
Morphology in Electron Microscopy:
The morphology of the NMPN was observed using field emission Scanning electron microscopy (FE-TEM ) (JSM 2100, JEOL, Japan). One drop of properly diluted nanoparticles suspension was placed on a silicon substrate and air dried under ambient condition to study the morphology at various magnifications.
Loadi ng Efficiency of NMPN:
19 Loading efficiency of NRG was determined after the twice centrifugation at 12,000 rp m and 4 °C for 25min. 
Evaluati on of Mucoadhesi ve property:
Swelling Study: 20 The swelling studies on NMPN were performed with 0.1N HCl (pH 1.2) and phosphate buffer (pH 7.4). In brief, 100 mg of NMPN accurately weighed and immersed in 0.1N HCl and phosphate buffer, and kept for 24 hrs. The swelling index (SI) was calculated by using the following formula: SI = (W iWs/ Ws) X 100. Where SI= percentage of swelling of nanoparticles, Wi = in itial weight of nanoparticles, and Ws = weight of nanoparticles after swelling.
In-vitro mucoadhesion studies: 21 Naringeninloaded gastroretentive mucoadhesive polymeric nanoparticles were immersed in a 50 ml glass beaker at 37 °C containing a 0.1N HCl (pH 1.2). Fresh rat gastric mucosa was cut into 2 X 3cm and was placed on nanoparticles surface. Gastric mucosa was removed after 30 min and mucosa with the attached nanoparticles were removed and the remaining particles on the glass beaker were dried at 60 °C till constant weight. Percent of adhered nanoparticles (AN) was estimated using the following equation: AN (%) = (Wo -Wr/ Wo) X 100. Where, Wo is the initial weight of nanoparticles and Wr the remained unattached weight of nanoparticles.
In vitro release studies:
The in vitro drug release studies were conducted in stimulated gastric fluid (pH 1.2) and stimulated intestinal fluid (pH 6.8). An appropriate amount of NMPN was placed in a beaker containing 50 ml of simulated gastric fluid and intestinal fluid at 37 with shaking conditions. 0.1 ml of flu id was withdrawn at each time point periodically and replaced with the same volu me of fresh fluid and the amount of drug was quantified by HPLC analysis.
Evaluati on of Pharmacokinetic Profile:
Animals and Dosing: All the animal study protocols were duly approved by the Institutional Animal Ethics Co mmittee, India. Male Wister strain rats weighing 200-250 g were maintained in controlled room temperature (20°C ± 2°C) and relative humidity (60% ± 10%) on 12 hrs light/dark cycle. Water and commercial laboratory complete food for rats were available ad libitum. They were acclimat ized to this environment for 7 days before receiving experimental treat ment. The animals were randomly distributed into two groups each containing six animals. Different groups of animals received oral dose of free NRG (20 mg/ kg) and NMPN (20 mg/ kg). Blood samp les (appro ximately 0.5ml) were collected at periodic time intervals (0, 4, 8, 12 , 16, 20 and 24 hrs) from the retro-orbital plexus. After each sampling, 1ml of dextrose-normal saline was administered orally to prevent changes in the central compart ment volume and electrolytes. Plasma was separated by centrifuging the blood samples at 10,000 rpm for 10 min at 4 °C and kept at -80 °C until analyzed.
Deter minati on of naringenin in rat pl asma by HPLC:
Naringenin in rat p lasma was analyzed by HPLC using a mixture of acetonitrile and 2% acetic acid in a volume ratio of 51:49 (v/v) as the mobile phase at a flow rate of 1.0 ml ⋅ minute−1. For the measurement of plasma NRG, 50 μ l of internal standard solution (hesperitin, 4 μg ⋅ ml−1 in ethanol) was added to 0.2 ml plasma. After vortex mixing for 1 min, 500 μl of anhydrous diethyl ether was added and again vortexmixed for 1 min. After centrifugation at 10,000 rp m for 10 min, the supernatant was withdrawn and evaporated under a light stream of nitrogen at room temperature. The residue was dissolved in 100 μ l of the mobile phase and again centrifuged at 10,000 rp m for 10 min. 20 μl of the supernatant was then injected for HPLC analysis. Quantificat ion was based on the peak area ratio R (ACUR/AEMO). The calibration curve obtained was R = 0.0023C + 0.0335 (r = 0.9998, n = 5), with a correlation coefficient 0.999. The pharmacokinetic parameters of free NRG as well as NMPN groups were calculated by using noncompart mental method. The area under the curve and the mean residence time were determined by standard methods applying the linear trapezoidal rule.
STATISTICAL ANALYS IS
GraphPad Pris m 5 software was used for statistical analysis (GraphPad Software Inc., San Diego, USA). Data are exp ressed as mean ± SD. Data were analyzed by one-way analysis of variance (ANOVA) followed by the Student-Newman-Keul mu ltiple comparison test. Differences were considered significant at P< 0.05.
RES ULTS AND DISCUSS ION:
NMPN were formu lated by a simple nanoprecipitation method with thermal decomposition approaches. Nanoprecipitation is a simplistic and mild process technique for the preparation of nano scale compounds and it was one of the most superior to other encapsulation methods. 22 During the particle synthesis both internal phases of NRG and EE 100 are hydrophobic in nature interacts each other and form a suspension. These internal phase suspension was introduced into external aqueous phase and produce interfacial tension to form stronger outer surface with the help of PVA as a stabilizer. Nanoprecipitat ion was conducted through the precipitation of a performed polymer fro m an organic solution which was previously solubilized, with the diffusion of this organic solvent into the aqueous mediu m. In the aqueous phase, the polymers get insoluble, prec ipitating immediately leading to the format ion of nanoparticles. 23 In addition to that under thermal decomposition by means of the mixtu re face above melting temperature and it was cooled very slowly to form crystals which results in the formulat ion of cubic particles. 24, 25, 26 Figure 1a showed the mean particle size distribution of the formulated nanoparticles. Nanoparticles size is a useful parameter since its affects the drug loading and release. The size distribution of the formulated NMPN was smaller with narrow distributions. The magnitude of the zeta potential on the NMPN was relat ively high due to their stronger electrostatic repulsion that inhibits the particle aggregation 27 that showed in Figure 1b. (a) (b) Figure 1 : The Graphica l representation of (a) mean particle size; (b) zeta potential of formu lated naringenin-loaded gastroretentive mucoadhesive polymeric nanoparticles.
Formulated NMPN were characterized by 1 H NMR and FTIR, the hydrogen bonding of free NRG as well as NMPN were showed in Figure 2 . Hydrogen bonding formation can be accounted by chemica l shift changes in compound. 28, 29 The spectrum of free NRG showed protons on aromatic groups ranging fro m H6 -H8 (6.77-6.79ppm) and strong intra molecular hydrogen bonding at 12.14ppm. Where NM PN showed that the aromatic protons were shifted and the intra mo lecular hydrogen bonding disappeared.
The spectrum of NMPN showed protons on aromat ic group from H6 -H8 was shifted to about 0.1ppm. In frared spectroscopy was used to study the interactions between the drug and the polymers that showed in Figure 3 . Functional characteristics peak for drug in the region of 3849cm -1 . An FTIR spectrum of NMPN does not have a characteristic peak indicating that drug had been loaded into nanoparticles. NMPN spectra did not show any changes in characteristic peaks for EE-100 and PVA in the region of 1390-1370cm -1 and 1407cm -1 respectively, its indicating that polymer and stabilizer inter connected with outer layer in nanostructure. Nanoparticles mo rphology was shown in Figure 4 . The particles had a cubic morphology with a smooth surface with no polymeric aggregates. Particles are smaller in size, among most of them are similar in dimensions. Hydrodynamic process takes place during the particle preparation which leads to the higher loading efficiency of NRG in surrounding aqueous phase. When adjusting the proportion of stabilizer (PVA ) in aqueous phase that influencing the loading efficiency of NRG. The possible reason was the hydrophobic nature of EE 100 interpenetrates into the hydrophilic nature of PVA during particle preparation and remained that trapped to the matrix structure.
The loading efficiency of NMPN was showed in Table 1 . Hydrodynamic process takes place during the particle preparation which leads to the higher encapsulation of NRG in surrounding aqueous phase. The hydrophobic nature of EE 100 interpenetrates into the hydrophilic nature of PVA during particle preparation and remained that trapped to the matrix structure. Table 1 : Determination of mean particle size, zeta potential, poydispersity index (PDI) and loading efficiency of blank Nanoparticles (NP) and formu lated NMPN (mean ± SD, n = 3).
Nanoparticles
Size ( The pH is one of the major factors that significantly influence the swelling behavior of a system. The p H responsive system has been most frequently used to design controlled release formulat ions for oral ad min istration of drug, which remains the most clinically acceptable way of drug delivery. 30 The present study the effect of pH on the swelling behavior of NMPN was investigated at pH of 1.2 and 7.4 which represents the pH conditions of stomach and blood respectively. The swelling results are shown in Figure 5 which indicates a significant faith of swelling behavior of the NMPN on different pH concentrations. The results revealed at pH 1.2, a h igher swelling ratio was found when compared to pH 7.4 which is due to the mucoadhesive polymer used for the preparation of nanoparticles. Mucoadhesive studies had been done in order to assess the adhesion of NMPN on gastric mucosal membrane. NM PN shows satisfactory adhesion property which is due to the mucoadhesive polymer used. Mucoadhesive property of EE 100 are mostly dependent on the ionic interaction of positively charged amine group of EE 100 with negatively charged ions present within mucus membrane of sulfonic acid and sialic acid residues. The release profile of NMPN in stimulated gastric and intestinal fluids showed in Figure 6 (a & b) . Eudragit E 100 is a copoly mer o f methacrylic ac id and ethyl acrylate that soluble below the pH of 4.5. It should therefore be possible to design polymeric system that loaded and protect bioactive compounds within acidic environments (site specific, stomach). We therefore investigated the release of NRG fro m NMPN. In NM PN the drug was released up to 24 hrs in stimulated gastric flu id thus indicating long acting controlled release with high precision. Therefore the prolonged release pattern of NRG which might contributes to reduce the frequent dose and enhances the drug absorption. The plasma concentration time profile of free NRG and NMPN showed in Figure 7 . Main pharmacokinetics parameters in plas ma as well as stomach tissue homogenate following a single oral administration of 20mg/ kg body weight in rats showed in Table 2 . NMPN is well absorbed due to the controlled release in ac idic media without degradation of the drug when compared with the free NRG. The pharmacokinetic parameters AUC and MRT show significant differences between free NRG and NMPN in plasma and stomach tissue homogenate. Longer residence time in stomach tissue homogenate allows more active components to penetrate through the gastric mucus memb rane and to be absorbed above the absorption zone. 31 Therefore, the formulated NMPN are suitable for stomach specific delivery. A UC -area under the curve; MRT -mean residence time
CONCLUS ION
The naringeninloaded gastroretentive mucoadhesive polymeric nanoparticles has been formulated by a facile nanoprecipitation method under thermal decomposition. The formu lated NMPN have been smaller in size with higher stability and higher drug loading efficiency. The morphology was evidenced by FE-TEM and functional characteristics were confirmed by FTIR and 1 H NMR. The Sustained drug release of NRG was prolonged up to 24 hrs in stimulated gastric fluid. Swelling and mucoadhesion studies demonstrated that NMPN exhib ited good mucoadhesive in nature. Thus the results of the present study were suggested that the NMPN was found to be a sustained drug delivery vehicle with prolonged release when injected in the form of o ral delivery. Pharmacokinetic fate was investigated in NMPN, they have a site specific delivery in stomach due to increased AUC and residence time as compared to free NRG. Further, the toxicity will be assessed in vitro and in vivo tumor models, in order to explore its therapeutic efficacy in the field o f bio med ical application.
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